| Stacey Lynne Lecours, MS, CCC/SLP | |
|
1225 Wordens Pond Rd, Charlestown, RI 02813-3738 | |
| (401) 782-4709 | |
| Not Available |
| Full Name | Stacey Lynne Lecours |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1225 Wordens Pond Rd, Charlestown, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730344250 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SP00446 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Stacey Lynne Lecours, MS, CCC/SLP 1225 Wordens Pond Rd, Charlestown, RI 02813-3738 Ph: (401) 782-4709 | Stacey Lynne Lecours, MS, CCC/SLP 1225 Wordens Pond Rd, Charlestown, RI 02813-3738 Ph: (401) 782-4709 |
News Archive
A new piece in Family Practice, published by Oxford University Press, indicates that tracking symptoms affiliated with the novel coronavirus through an app may not be a good predictor of the spread of the disease.
As many as 3,750 medical laboratories, all but 75 of which are in the U.S., have been told by the World Health Organization to destroy a pandemic flu virus sent to them as part of routine testing kits.
Adeona Pharmaceuticals, Inc., announced five scientific publications on the role of copper toxicity and zinc deficiency in Alzheimer's disease and cognitive decline.
A new 3D structure for growing cell cultures could enable doctors to test medications on model tumors grown from a patient's own cells, according to results from a team of engineers and cancer researchers at the University of Michigan.
› Verified 6 days ago